VEGFA and neoplasm: Figure 2B also demonstrated that EGCG treatment reduced plasma VEGF levels over the control mice (26.48 ± 3.76 vs. 40.79 ± 3.5 pg/ml; n = 8; P < 0.01) and tumor VEGF expression over the control mice (45.72 ± 1.4 vs. 59.03 ± 3.8 pg/mg; n = 8; P < 0.01).